Accession Number: | 0000899243-23-003525 |
Date: | 2023-01-31 |
Issuer: | LYRA THERAPEUTICS, INC. (LYRA) |
Original Submission Date: |
RICHARD ROBERT E.
C/O LYRA THERAPEUTICS, INC.
480 ARSENAL WAY
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-01-31 | A | 30,000 | a | $0.00 | 30,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 2.85 | 2023-01-31 | deemed execution date | A | 45,000 (a) | 2033-01-30 | common stock 45,000 | $2.85 | 45,000 | direct |
ID | footnote |
---|---|
f1 | represents an award of restricted stock units ("rsus"). each rsu represents a contingent right to receive one share of the issuer's common stock. the rsus will vest in four (4) equal annual installments on the first four anniversaries of the grant date such that the rsus will fully vest on january 31, 2027. |
f2 | this option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the reporting person's service to the issuer following january 31, 2023. |